Verrica Pharmaceuticals Inc
VRCA
$3.60-4.89%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$79.72M
EV/Sales
1.39
P/E ratio
N/A
FY2025 Revenue
$35.58M
EPS (TTM)
$-1.74
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-50.27%
Beta
1.76
Div yield
N/A
Sector
Healthcare
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported VRCA revenue for 2025-12-31 was $35.6M. Net income was -$17.9M. Revenue was up 370.2% from 2024-12-31 to 2025-12-31. VRCA currently screens at market cap $79.7M.
Use this VRCA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VRCA income, balance, and cash tables.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company in the Healthcare sector.
Latest cached Verrica Pharmaceuticals Inc (VRCA) revenue for Dec 31, 2025 was $35.6M. Net income was -$17.9M. Statements: https://lician.com/financials/vrca
Verrica Pharmaceuticals Inc (VRCA) market capitalization is $79.7M on the latest cached snapshot.
Verrica Pharmaceuticals Inc (VRCA) cached previous close $3.78; day range $3.48 – $3.95; volume 116,428. Session quote: https://lician.com/quote/vrca
Verrica Pharmaceuticals Inc (VRCA) latest cached earnings event is "VRCA earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VRCA filing is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/vrca